11 selected records with a cited source date in 1997. This archive is selective and does not imply continuous monitoring or complete historical coverage.
The Federal Register published notice 97-32874, attributed to FDA and its parent HHS department, on 1997-12-17. Its official title is “Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Eptifibatide.
The Federal Register published notice 97-30614, attributed to FDA and its parent HHS department, on 1997-11-21. Its official title is “Determination That Desmopressin Acetate Nasal Solution 0.01% (for Refrigerated Storage) Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Desmopressin.
The official Drugs@FDA dataset lists original submission 1 for ANDA 074888 with status AP dated 1997-10-15, and names desmopressin acetate among the application record's active ingredients.
The official Drugs@FDA dataset lists original submission 1 for NDA 020443 with status AP dated 1997-09-26, and names sermorelin acetate among the application record's active ingredients.
The Federal Register published notice 97-20871, attributed to FDA and its parent HHS department, on 1997-08-07. Its official title is “Sterling Drug, Inc., et al.; Withdrawal of Approval of 28 New Drug Applications, 9 Abbreviated Antibiotic Applications, and 46 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.
The Federal Register published notice 97-19065, attributed to FDA and its parent HHS department, on 1997-07-21. Its official title is “Babineaux's Veterinary Products, Inc., et al.; Withdrawal of Approval of NADA's,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.
The Federal Register published rule 97-19066, attributed to FDA and its parent HHS department, on 1997-07-21. Its official title is “Animal Drugs, Feeds, and Related Products,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.
The Federal Register published rule 97-16967, attributed to FDA and its parent HHS department, on 1997-06-30. Its official title is “Animal Drugs, Feeds, and Related Products; Change of Sponsor,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.
The Federal Register published notice 97-10911, attributed to FDA and its parent HHS department, on 1997-04-28. Its official title is “Environmental Assessments and Findings of No Significant Impact,” and PeptideScanner's exact reviewed identity mapping connects the document to Goserelin.
The Federal Register published notice 97-10541, attributed to FDA and its parent HHS department, on 1997-04-23. Its official title is “Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Mecasermin.
The official Drugs@FDA dataset lists original submission 1 for NDA 020708 with status AP dated 1997-03-07, and names leuprolide acetate among the application record's active ingredients.